The Mid-Term View: Observing Tangible Momentum (Weeks 4-12) Now we're getting somewhere
Cardiovascular Protection: Major clinical trials like the LEADER trial for liraglutide have shown that GLP-1 RAs can significantly reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes
Ongoing support: App with tracking features, community support, health coach messaging, and AI for quick questions Found Pricing: Self-Pay vs
GLP-1 receptor agonists like semaglutide and tirzepatide act on incretin pathways through GLP-1 and GIP receptors, with central appetite suppression and slowed gastric emptying as primary mechanisms
Best suited for retatrutide are non-surgical skin tightening patients, specifically patients dealing with skin laxity from weight loss, following an in-depth consultation